Ocugen NASDAQ OCGN stock price at Cantor Fitzgerald

Why Did Ocugen Share Price Fall 6.7% this Week? | IG UK


Fitzgerald was downgraded from “overweight” to “neutral” in a survey released on Friday, according to Analyst Price Targets. The stock already has a price target of 11.00 dollars. The price target set by Cantor Fitzgerald indicates a possible gain of 19.76 percent from the stock’s previous close. Ocugen’s FY2022 earnings are expected to be 2.69 dollars a share, according to Cantor Fitzgerald.

NASDAQ OCGN has also been the subject of research from a host of other equities analysts. In a research report issued on February 9th, Chardan Capital downgraded Ocugen from a “buy” to a “neutral” price. Zacks Investment Research downgraded Ocugen from a hold to a selling price in a research note released on Wednesday. In a research note issued on Thursday, March 4th, Roth Capital lifted its price objective on Ocugen from 9.00 to 10.00 dollars and gave the company a “buy” recommendation.

Finally, in a research note issued on Thursday, February 4th, HC Wainwright upgraded Ocugen from a “neutral” to a “buy” rating and set a 4.50 dollars price target on the market. One investment analyst has given the stock a sell rating, two have given the stock a hold rating, and two have given the stock a purchase rating. The company currently has a consensus target price of 6.44 dollars and an average rating of “Hold.”

The stock of OCGN opened at 9.19 dollars. The company has a 1.73 billion dollar market value, a price-to-earnings ratio of -6.21, and a beta of 3.56. The firm has a 0.13 debt-to-equity ratio, a 4.78 fast ratio, and a 4.78 current ratio. The company’s 50-day simple moving average is $8.32, and its 200-day simple moving average is 4.66 dollars. Ocugen has traded between 0.17 and 18.77 dollars in the last year.

Best buy, sell the signal system

On Wednesday, March 17th, Ocugen NASDAQ OCGN at https://www.webull.com/quote/nasdaq-ocgn released its quarterly earnings report. The firm posted 0.02 dollars EPS for the quarter, which was 0.04 dollars higher than the Thomson Reuters consensus estimate of 0.02 dollars. Ocugen NASDAQ OCGN is expected to report -0.28 earnings per share for the current fiscal year, according to analysts.

In other Ocugen news, on Monday, April 26th, Director Uday Kompella sold 350,000 shares of the company’s portfolio. The shares were exchanged for a total of 4,095,000.00 dollars at an average price of 11.70 dollars per share.

The director now owns 600,674 shares of the company’s stock, valued at 7,027,885.80 dollars, following the transaction. The stock was exchanged for a total of 39,975.00 dollars at an average price of 5.33 dollars. As a result of the sale, the director now owns 7,500 shares in the corporation, valued at 39,975 dollars. Before investing, you can check more stocks like nasdaq knbe at https://www.webull.com/quote/nasdaq-knbe.

About Marie C. Delgado

Check Also

Arts, Culture, Entertainment

Often these nonresidents search events which are genuine and that provide a memorable expertise. Data …